CPHI Webinar Series

Improved Delivery of Poorly Soluble Compounds Using Capsule Formulations

25th August, 2022
4pm CET / 10am EST
What will this webinar address?

In this webinar, two experts from Lonza will look at issues around drug solubility, and how bioavailability can be improved. Compounds that are poorly soluble in water are still prevalent in the drug development pipeline, and technologies such as amorphous solid dispersion (ASD) can be used to improve their bioavailability. This enables effective drug products to be made as tablets or capsules. You will find out how bioavailability enhancement techniques can contribute to the creation of successful drug products, and how Lonza’s Capsule Applications Services lab can also help by developing innovative capsules to tailor drug delivery and ensure the ASDs remain stable in the long term.

Why attend:

In this webinar, formulation scientists and pharmaceutical development specialists will learn
  • Learn about the main attributes of amorphous solid dispersions
  • Find out how these ASD's can help solve bioavaliability issues
  • Discover how Lonza’s new Capsule Applications Services lab can speed up capsule process development for poorly soluble compounds
  • David Lyon
    Senior Research Fellow

    David Lyon currently serves as a Sr. Fellow, Global R&D advising research in bioavailability enhancement, inhalation, modified release and bioprocessing. He received his BS in Chemistry from Western Washington University and PhD in Inorganic Chemistry from the University of Oregon. Following a Post-Doctoral stint at the California Institute of Technology, David joined Bend Research as a Research Chemist in 1991. During his tenure at Bend Research, he held positions of increasing responsibility, culminating in the role of Senior Vice President, Research prior to the company’s acquisition by Capsugel and, subsequently, Lonza. (DDS).

    Vincent Jannin
    Head of Applications Lab

    Dr. Vincent Jannin is Head of Capsule Applications Services at Lonza CHI. Previously, he held diverse positions up to Research Director at Gattefossé, and was a lecturer at Lyon University. Vincent earned his PharmD and PhD in Pharmaceutical Technology from the University of Bourgogne, and received his habilitation (HDR) from the University of Lyon.

    Vincent has published more than 140 peer-reviewed papers, and given more than 60 lectures on Drug Delivery Systems.

    This webinar is brought to you by

    Improved Delivery of Poorly Soluble Compounds Using Capsule Formulations
    • 25th August, 2022
    • 4pm CET / 10am EST
    • 60 minutes
    • Free
    CPHI Newsletter

    Get the latest from CPHI in your inbox every week.

    You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time by clicking on the Unsubscribe link in the Newsletters or opting out on our unsubscribe page page.